Thermo Fisher Scientific (TMO) Tops Q1 EPS by 19c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts TMO Hot Sheet
Price: $706.66 +1.19%
Financial Fact:
Cost of product revenues: 2.02B
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Cost of product revenues: 2.02B
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Thermo Fisher Scientific (NYSE: TMO) reported Q1 EPS of $5.44, $0.19 better than the analyst estimate of $5.25. Revenue for the quarter came in at $11.01 billion versus the consensus estimate of $10.87 billion.
For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- No Visa Required: SMX Passport Moves Physical Assets into the Digital Economy
- Twilio (TWLO) PT Raised to $320 at Tigress Financial Partners
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
